STrengthening the Reporting of OBservational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): An Extension of the STROBE Statement

被引：104

作者：

Gallo, Valentina ^{[1
,2
]}

Egger, Matthias ^{[3
]}

McCormack, Valerie ^{[4
]}

Farmer, Peter B. ^{[5
]}

Ioannidis, John P. A. ^{[6
,7
]}

Kirsch-Volders, Micheline ^{[8
]}

Matullo, Giuseppe ^{[9
,10
]}

Phillips, David H. ^{[11
]}

Schoket, Bernadette ^{[12
]}

Stromberg, Ulf ^{[13
]}

Vermeulen, Roel ^{[14
]}

Wild, Christopher ^{[4
]}

Porta, Miquel ^{[15
]}

Vineis, Paolo ^{[9
,16
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England

[2] London Sch Hyg & Trop Med, London WC1, England

[3] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland

[4] Int Agcy Res Canc, F-69372 Lyon, France

[5] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England

[6] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA

[7] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece

[8] Vrije Univ Brussel, Lab Cell Genet, Brussels, Belgium

[9] HuGeF Human Genet Fdn, Turin, Italy

[10] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy

[11] Inst Canc Res, Sutton, Surrey, England

[12] Natl Inst Environm Hlth, Budapest, Hungary

[13] Lund Univ, Div Occupat & Environm Med, Lund, Sweden

[14] Univ Utrecht, IRAS, Div Environm Epidemiol, Utrecht, Netherlands

[15] Univ Autonoma Barcelona, IMIM, E-08193 Barcelona, Spain

[16] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC HPA Ctr Environm & Hlth, London, England

来源：

PLOS MEDICINE | 2011年 / 8卷 / 10期

关键词：

PROGNOSTIC MARKERS; DNA-DAMAGE; BIOMARKERS; CANCER; VALIDATION; EXPOSURE; ARTICLES;

D O I：

10.1371/journal.pmed.1001117

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

[No abstract available]

引用

页数：12

共 54 条

[1]

Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.3.CO

[2]

2-X

[3]

[Anonymous], 2010, ETHICS DATA PROTECTI

[4]

[Anonymous], 2007, EPIDEMIOLOGICAL CONC

[5]

Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework [J].

Atkinson, AJ ;

Colburn, WA ;

DeGruttola, VG ;

DeMets, DL ;

Downing, GJ ;

Hoth, DF ;

Oates, JA ;

Peck, CC ;

Schooley, RT ;

Spilker, BA ;

Woodcock, J ;

Zeger, SL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :89-95

[6]

Epidemiology, Public Health, and the Rhetoric of False Positives [J].

Blair, Aaron ;

Saracci, Rodolfo ;

Vineis, Paolo ;

Cocco, Pierluigi ;

Forastiere, Francesco ;

Grandjean, Philippe ;

Kogevinas, Manolis ;

Kriebel, David ;

McMichael, Anthony ;

Pearce, Neil ;

Porta, Miquel ;

Samet, Jonathan ;

Sandler, Dale P. ;

Costantini, Adele Seniori ;

Vainio, Harri .

ENVIRONMENTAL HEALTH PERSPECTIVES, 2009, 117 (12) :1809-1813

[7]

Biomarkers in molecular epidemiology studies for health risk prediction [J].

Bonassi, S ;

Au, WW .

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2002, 511 (01) :73-86

[8]

Caporaso NE, 2002, CANCER EPIDEM BIOMAR, V11, P1544

[9]

An empirical assessment of validation practices for molecular classifiers [J].

Castaldi, Peter J. ;

Dahabreh, Issa J. ;

Ioannidis, John P. A. .

BRIEFINGS IN BIOINFORMATICS, 2011, 12 (03) :189-202

[10]

Uses and misuses of the STROBE statement: bibliographic study [J].

da Costa, Bruno R. ;

Cevallos, Myriam ;

Altman, Douglas G. ;

Rutjes, Anne W. S. ;

Egger, Matthias .

BMJ OPEN, 2011, 1 (01)

← 1 2 3 4 5 6 →